Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Cipla
Pharma
BMS, generics companies face new suit over Revlimid 'monopoly'
A class action antitrust lawsuit has been filed against BMS and a raft of generic drugmakers for allegedly maintaining a monopoly on Revlimid.
Kevin Dunleavy
Nov 22, 2022 11:38am
Gilead can't escape antitrust suit centered on Cipla deal
Aug 23, 2022 1:44pm
The top 10 generic drug makers by 2021 revenue
Jul 18, 2022 3:00am
Pfizer's MPP pact will provide COVID pill to 95 countries
Mar 18, 2022 10:05am
Tough decisions for Indian pharmas who do business with Russia
Mar 9, 2022 9:38am
Teva launches Revlimid generic, the first to do so in U.S.
Mar 7, 2022 11:11am
